Abstract. The aim of the present study was to look further into the question of local degradation of sc injected human GH in GH deficient patients. in the same 9 GH deficient patients. A 3-h lag period was interposed between the iv and the sc
lag period was interposed between the iv and the sc infusion. Iv infusion was continued for 3 h. All 9 subjects subsequently received sc infusion for 19 h and five of them continued for additionally 24 h. The mean steady state serum GH level in the nine patients was 23.1 \m=+-\5.1 \g=m\g/l after iv and 6.8 \m=+-\ \g=m\g/l after sc administration (P < 0.01). Extension of the sc infusion period in 4 of the subjects did not significantly alter the serum GH level (P > 0.15), implying that a steady state was reached. The GH in the infusion system was stable throughout a 24-h period. We therefore conclude that sc injected GH is degraded locally to a substantial extent.
GH replacement therapy has traditionally been administered as im injections twice or trice weekly.
The im route was originally chosen because sc injections had induced local atrophy and was suspected of inducing higher levels of GH anti¬ bodies (Underwood et al. 1973) . Recently, several investigators used the sc route without adverse effects (Christiansen et al. 1983; Wilson et al. 1985 
Results
The individual serum GH values are presented in Table 2 .
The mean serum GH levels during the last 45 min of the 3-h iv infusion and the last 3 h of the 19-h sc infusion in all 9 subjects are shown in Fig. 1 . The mean GH level during iv infusion was 23.1 ±5.1 pg/1 and during sc infusion 6.8 ± 1.6 pg/1. The difference between these 2 serum GH levels was highly significant (P = 0.002).
Patients No. 5-9 continued on sc infusion for an additional 24-h period. Their mean iv value was 25.6 ± 6.3. The mean value during the 16th -19th h of sc infusion was 7.4 ± 2.4 pg/1 and 8.7 ± 2.6 pg/1 during the 40th-43rd h of sc infusion. The difference between the iv and both the sc levels was significant (P < 0.05), whereas no sig¬ nificant difference was found between the 2 sc levels (P > 0.15). The results are depicted in Fig. 1 (Christiansen et al. 1983 ).
In theory, the observed difference could at least partly be due to a slower metabolic clearance rate at higher serum GH levels; however, it has been demonstrated that the elimination of GH follows first order kinetics even at high GH levels (Lauritzen et al. 1987) . Finally, our stability study showed no signs of in vitro degradation of GH in the observation period.
Although this evidence is basically circumstan¬ tial we conclude that sc injected GH is degraded locally to a substantial extent. This is in contrast to insulin, of which only a small fraction is degraded if any. In addition insulin is absorbed much faster from the sc tissue than GH (Binder 1969; Lauritzen 1985) . One could speculate that GH, having a molecular weight of more than 3 times that of insulin, to some extent is transported by the lymphatic system thereby being more exposed to degradation. This could also explain the slower absorption of GH than of insulin. (Christiansen et al. 1983; j0rgensenetal. 1987) .
In our opinion, the present data should not be held as evidence against sc injections of GH. But one could speculate that some of the children who do not respond satisfactorily to GH therapy might be 'GH resistant' owing to a massive local degrada¬ tion. Perhaps measurement of serum GH after GH injections should be performed in such cases.
In all instances, the recognition of sc degrada¬ tion of GH should be born in mind by future investigators of the pharmacokinetic and biologi¬ cal properties of GH therapy.
